Capsid-mediated interactions in HIV assembly
HIV组装中衣壳介导的相互作用
基本信息
- 批准号:7230861
- 负责人:
- 金额:$ 22.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAdoptedAmino Acid SequenceAmino AcidsAnti-HIV AgentsAnti-Retroviral AgentsAntiviral AgentsArchitectureBiological AssayC-terminalCapsidCapsid ProteinsCharacteristicsComplexDataDefectDevelopmentDimerizationDisruptionDominant-Negative MutationDrug Delivery SystemsDue ProcessElementsEpidemicEventGaggingHIVHIV BuddingHIV drug resistanceHealthHomologous GeneHumanIn VitroInfectious AgentLeadLibrariesLife Cycle StagesLong Terminal RepeatsMapsMass Spectrum AnalysisMediatingMethodsModelingMolecularMolecular ConformationMutagenesisNMR SpectroscopyNaturePeptidesPharmaceutical PreparationsPhenotypePreclinical Drug EvaluationProcessPropertyProteinsResearch PersonnelResistanceRetrotransposonRetroviridaeRoleScanningSideSolutionsStretchingStructureTestingViralViral ProteinsVirus-like particleZinc Fingersbasecrosslinkdesigndimergag Gene Productshigh throughput screeningin vivoinhibitor/antagonistinsightmutantnovelparticlepathogenprogramssmall molecule
项目摘要
DESCRIPTION (provided by applicant): The AIDS epidemic caused by the HIV retrovirus is one of the leading threats posed to global health by an infectious agent. Limited availability of expensive anti-HIV drugs in the developing world, as well as emergence of drug-resistant HIV strains, highlight the continued need for identification and development of novel HIV prevention and treatment methods, drug targets and drugs. Disruption of viral assembly is a promising antiviral treatment strategy, but the progress in this direction has been slow due to the multivalent nature of the viral assembly process and due to the lack of efficient assembly assays suitable for drug screening and lead optimization. Our recent results revealed an evolutionary relationship between the zinc- finger associated SCAN domain and the retroviral capsid C-terminal domain (CA-CTD), and suggested a mechanism for capsid-mediated Gag oligomerization in retroviral assembly. The main hypothesis of this proposal is that the domain-swapped dimer observed in the SCAN structure represents a critical conformation of CA-CTD adopted during viral assembly. The functional clues provided by the SCAN structure will be used to identify critical molecular determinants of capsid dimerization, and to investigate the proposed role of the SCAN-like domain-swapped CA-CTD dimer (Aim 1). Sensitive and robust assays of CA-CTD dimerization will be developed and used for identification of capsid dimerization inhibitors by high throughput screening and rational design. The anti-HIV potential of the identified compounds will be evaluated (Aim 2).
描述(申请人提供):由艾滋病毒逆转录病毒引起的艾滋病流行是由传染病病原体对全球健康构成的主要威胁之一。发展中国家昂贵的抗艾滋病毒药物供应有限,以及出现具有抗药性的艾滋病毒毒株,这些都突出表明,仍有必要确定和开发新的艾滋病毒预防和治疗方法、药物靶标和药物。破坏病毒组装是一种很有前途的抗病毒治疗策略,但由于病毒组装过程的多价性以及缺乏适合于药物筛选和先导优化的有效组装分析,这一方向的进展缓慢。我们最近的结果揭示了锌指相关扫描域和逆转录病毒衣壳C末端结构域(CA-CTD)之间的进化关系,并提示了逆转录病毒组装中衣壳介导的Gag寡聚的机制。这一建议的主要假设是,在扫描结构中观察到的结构域交换的二聚体代表了病毒组装过程中采用的CA-CTD的关键构象。由扫描结构提供的功能线索将被用于识别衣壳二聚的关键分子决定因素,并研究扫描样结构域交换的CA-CTD二聚体的拟议作用(目标1)。通过高通量筛选和合理设计,将建立灵敏和可靠的CA-CTD二聚分析方法,用于衣壳二聚抑制剂的鉴定。将对已确定化合物的抗艾滋病毒潜力进行评估(目标2)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DMITRI N IVANOV其他文献
DMITRI N IVANOV的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DMITRI N IVANOV', 18)}}的其他基金
Biochemistry of SAMHD1-mediated innate immunity responses
SAMHD1 介导的先天免疫反应的生物化学
- 批准号:
10212922 - 财政年份:2019
- 资助金额:
$ 22.74万 - 项目类别:
Biochemistry of SAMHD1-mediated innate immunity responses
SAMHD1 介导的先天免疫反应的生物化学
- 批准号:
10445349 - 财政年份:2019
- 资助金额:
$ 22.74万 - 项目类别:
Retroviral capsid recognition by TRIM5alpha restriction factors
TRIM5alpha 限制因子识别逆转录病毒衣壳
- 批准号:
9262531 - 财政年份:2014
- 资助金额:
$ 22.74万 - 项目类别:
Retroviral capsid recognition by TRIM5alpha restriction factors
TRIM5alpha 限制因子识别逆转录病毒衣壳
- 批准号:
8732420 - 财政年份:2014
- 资助金额:
$ 22.74万 - 项目类别:
Structural Basis of Retroviral Restriction by TRIM5alpha
TRIM5alpha 限制逆转录病毒的结构基础
- 批准号:
7898613 - 财政年份:2009
- 资助金额:
$ 22.74万 - 项目类别:
Structural Basis of Retroviral Restriction by TRIM5alpha
TRIM5alpha 限制逆转录病毒的结构基础
- 批准号:
7755507 - 财政年份:2009
- 资助金额:
$ 22.74万 - 项目类别:
Structural Basis of Retroviral Restriction by TRIM5alpha
TRIM5alpha 限制逆转录病毒的结构基础
- 批准号:
8055204 - 财政年份:2009
- 资助金额:
$ 22.74万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 22.74万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 22.74万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 22.74万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 22.74万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 22.74万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 22.74万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 22.74万 - 项目类别: